The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company’s dog vaccines market report forecasts the dog vaccines market size to grow to $4.14 Billion by 2027, with a CAGR (compound annual growth rate) of almost 5%.

Learn More On The Dog Vaccines Market Report 2023 – https://www.thebusinessresearchcompany.com/report/dog-vaccines-global-market-report

Dog Vaccines Market Size Forecast
The global dog vaccines market is expected to grow from $3.23 billion in 2022 to $3.42 billion in 2023 at a compound annual growth rate (CAGR) of 6.1%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The dog vaccines market size is expected to grow to $4.14 billion in 2027 at a CAGR of 4.9%.

Asia-Pacific held the largest dog vaccines market share.

Key Dog Vaccines Market Driver ­– Rise In The Adoption Of Pet Dogs
For instance, according to the National Pet Owners Survey by the American Pet Products Association 2021-2022, a US-based not-for-profit industry association, 70% of households in the United States owned a pet, which was equal to 90.5 million homes. Out of this, a total of 69 million U.S. households owned a dog as a pet, which was the highest compared to other animals as pets. Thus, the rise in the adoption of pet dogs is driving the growth of the dog vaccine market.

Request for A Sample Of The Global Dog Vaccines Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8443&type=smp

Key Dog Vaccines Market Trend – Technological Advancement
Major companies operating in the dog vaccine market are advancing toward the use of novel technology for vaccine development. For instance, in September 2022, Merck Animal Health, a US-based company providing veterinary pharmaceuticals, vaccines, and technology solutions, launched Nobivac Intra-Trac Oral BbPi, the first oral vaccine with mucosal protection and easy oral administration. It is used for the vaccination of healthy dogs aged 7 weeks or older against canine parainfluenza virus and Bordetella bronchiseptica. Additionally, it includes the novel technology, Immuno-Mist-R technology by Intervet, a Merck & Co subsidiary. This revolutionary technology, Immuno-Mist-RTM, dramatically increases mucosal surface area contact.

Dog Vaccines Market Segment
1) By Type: Attenuated Live Vaccines, Conjugate Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, DNA Vaccines, Recombinant Vaccines
2) By Route Of Administration: Subcutaneous, Intramuscular, Intranasal
3) By Application: Below 6 Months, Above 6 Months

Dog Vaccines Market Major Players and Strategies
Major players in the dog vaccines market are Bayer AG, Vetoquinol S.A, Boehringer Ingelheim, Ceva Sante Animale, Heska Corporation, Merck & Co Inc., Virbac, Elanco Animal Health Incorporated, Zoetis Inc., CZ Vaccines, Indian Immunologicals Ltd., Sanofi S.A., Cymedica, Creative Biolabs Inc. and Meiji Holdings Co Ltd.

In January 2021, Boehringer Ingelheim, a Germany-based pharmaceutical company with a broad portfolio of pharmaceutical products including animal vaccines, partnered with PetMedix to develop new and transformative antibody therapeutics for companion animals by leveraging PetMedix’s proprietary Ky9 platform. In this collaboration, PetMedix would be discovering therapies against a number of key targets, while Boehringer Ingelheim would be developing and commercializing them. Only PetMedix has brought this innovative approach to veterinary medicine with its Ky9TM platform, which can generate fully canine therapeutic antibodies rapidly and efficiently. PetMedix is a UK-based developing-stage veterinary biopharmaceutical company developing antibody-based therapeutics for companion animals.

The Dog Vaccines Global Market Report 2023 covers regional data on dog vaccines market size, dog vaccines market trends and drivers, opportunities, strategies, and dog vaccines market competitor analysis. The countries covered in the dog vaccines market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

Dog vaccines refer to injections that are given to dogs in series starting at the puppy stage and continuing into adulthood. These vaccines are used to introduce tiny amounts of a virus particle to induce an immune response in the body. In this way, if the dog’s body is exposed to this bacteria or virus, it can mount an immune response and prevent sickness.

View More Reports Related To The Dog Vaccines Market –
Pet Food Global Market Report 2023
Veterinary Healthcare Global Market Report 2023
Companion Animal Pharmaceuticals Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on: